Fármacos de uso frecuente en dermatología como terapia para COVID-19 | Zendy

M. Ortega-Peña | Zendy; Rubén GonzálezCuevas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Fármacos de uso frecuente en dermatología como terapia para COVID-19

Author(s) -

M. Ortega-Peña,

Rubén GonzálezCuevas

Publication year - 2020

Publication title -

actas dermo-sifiliográficas

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.272

H-Index - 37

eISSN - 1578-2190

pISSN - 0001-7310

DOI - 10.1016/j.ad.2020.09.004

Subject(s) - hydroxychloroquine , medicine , covid-19 , humanities , gynecology , disease , infectious disease (medical specialty) , philosophy

Researchers the world over are working to find the treatments needed to reduce the negative effects of coronavirus disease 2019 (COVID-19) and improve the current prognosis of patients. Several drugs that are often used in dermatology are among the potentially useful treatments: ivermectin, antiandrogenic agents, melatonin, and the antimalarial drugs chloroquine and hydroxychloroquine. These and other agents, some of which have proven controversial, are being scrutinized by the scientific community. We briefly review the aforementioned dermatologic drugs and describe the most recent findings relevant to their use against COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research